Blue Lizard Sensitive Face Sunscreen
- Product NDC
- 0316-2056
- 11-digit product format
- 003162056
- Labeler code
- 0316
- Product ID
- 0316-2056_4833f590-ba14-c376-e063-6294a90a529c
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Titanium Dioxide, Zinc Oxide
- Dosage form
- GEL
- Route
- TOPICAL
- Labeler
- Crown Laboratories
- Application
- M020
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2019-01-30
- Substance
- TITANIUM DIOXIDE; ZINC OXIDE
- Active strength
- 10; 83.4 mg/g; mg/g
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Blue Lizard Sensitive Face Sunscreen
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TITANIUM DIOXIDE | 10 mg/g |
| ZINC OXIDE | 83.4 mg/g |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 15FIX9V2JP, SOI2LOH54Z |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0316-2056-17 | Blue Lizard Sensitive Face Sunscreen | 1 in 1 CARTON | GEL | 1 | | 6 |
| 0316-2056-17 | Blue Lizard Sensitive Face Sunscreen | 48 g in 1 TUBE | GEL | 48 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0316-2056 | BLUE LIZARD SENSITIVE FACE SUNSCREEN (TITANIUM DIOXIDE, ZINC OXIDE) GEL [CROWN LABORATORIES] | 4 | Current NDC, Legacy NDC, 2 package rows | 20231206_88dbd396-8955-271e-e053-2995a90a0a7a.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0316-2056-17 | 00316205617 | 1 TUBE in 1 CARTON (0316-2056-17) / 48 g in 1 TUBE | 1 tube | 2019-01-30 | 0000-00-00 | No | No | Current |